Literature DB >> 8195401

Factors influencing detection of quantitative cytomegalovirus antigenemia.

M Boeckh1, P M Woogerd, T Stevens-Ayers, C G Ray, R A Bowden.   

Abstract

Of 20 blood specimens testing positive for cytomegalovirus antigen after immediate processing, 19 (95%) remained positive when kept at room temperature for 24 h before processing. Quantitative antigenemia decreased by an average of 44% after storage. Compared with acetone fixation, formaldehyde fixation showed improved readability, fewer artifacts, and a higher degree of sensitivity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8195401      PMCID: PMC263134          DOI: 10.1128/jcm.32.3.832-834.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

1.  Cytomegalovirus antigenemia as a useful marker of symptomatic cytomegalovirus infection after renal transplantation--a report of 130 consecutive patients.

Authors:  A P van den Berg; W van der Bij; W J van Son; J Anema; M van der Giessen; J Schirm; A M Tegzess; T H The
Journal:  Transplantation       Date:  1989-12       Impact factor: 4.939

Review 2.  Direct detection of cytomegalovirus in peripheral blood leukocytes--a review of the antigenemia assay and polymerase chain reaction.

Authors:  T H The; M van der Ploeg; A P van den Berg; A M Vlieger; M van der Giessen; W J van Son
Journal:  Transplantation       Date:  1992-08       Impact factor: 4.939

3.  Cytomegalovirus antigen detection in peripheral blood leukocytes after allogeneic marrow transplantation.

Authors:  M Boeckh; R A Bowden; J M Goodrich; M Pettinger; J D Meyers
Journal:  Blood       Date:  1992-09-01       Impact factor: 22.113

4.  Cytomegalovirus antigenemia assay.

Authors:  M van der Giessen; T H The; W J van Son
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

5.  Prospective study of cytomegalovirus antigenemia in allograft recipients.

Authors:  H Miller; E Rossier; R Milk; C Thomas
Journal:  J Clin Microbiol       Date:  1991-05       Impact factor: 5.948

Review 6.  Cytomegalovirus antigenemia.

Authors:  T H The; W van der Bij; A P van den Berg; M van der Giessen; J Weits; H G Sprenger; W J van Son
Journal:  Rev Infect Dis       Date:  1990 Sep-Oct

7.  The detection of human cytomegalovirus immediate early antigen in peripheral blood leucocytes.

Authors:  G Bein; A Bitsch; J Hoyer; H Kirchner
Journal:  J Immunol Methods       Date:  1991-03-21       Impact factor: 2.303

8.  The correlation between symptomatic CMV infection and CMV antigenemia in heart allograft recipients.

Authors:  P K Koskinen; M S Nieminen; S P Mattila; P J Häyry; I T Lautenschlager
Journal:  Transplantation       Date:  1993-03       Impact factor: 4.939

9.  Prediction of recurrent cytomegalovirus disease after treatment with ganciclovir in solid-organ transplant recipients.

Authors:  A P van den Berg; W J van Son; E B Haagsma; I J Klompmaker; A M Tegzess; J Schirm; G Dijkstra; M van der Giessen; M J Slooff; T H The
Journal:  Transplantation       Date:  1993-04       Impact factor: 4.939

10.  Comparison between viremia and antigenemia for detection of cytomegalovirus in blood.

Authors:  W van der Bij; J Schirm; R Torensma; W J van Son; A M Tegzess; T H The
Journal:  J Clin Microbiol       Date:  1988-12       Impact factor: 5.948

View more
  23 in total

1.  Comparison of PCR, antigenemia assay, and rapid blood culture for detection and prevention of cytomegalovirus disease after lung transplantation.

Authors:  A Weinberg; T N Hodges; S Li; G Cai; M R Zamora
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Enhanced analytical sensitivity of a quantitative PCR for CMV using a modified nucleic-acid extraction procedure.

Authors:  A Ferreira-Gonzalez; S Yanovich; M R Langley; L A Weymouth; D S Wilkinson; C T Garrett
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

3.  Clinical relevance of direct quantification of pp65 antigenemia using flow cytometry in solid organ and stem cell transplant recipients.

Authors:  A S Poirier-Toulemonde; N Milpied; D Cantarovich; J F Morcet; S Billaudel; B M Imbert-Marcille
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

4.  Comparison of the CMV brite turbo assay and the digene hybrid capture CMV DNA (Version 2.0) assay for quantitation of cytomegalovirus in renal transplant recipients.

Authors:  S K Ho; F K Li; K N Lai; T M Chan
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

5.  Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR.

Authors:  Michael Boeckh; MeeiLi Huang; James Ferrenberg; Terry Stevens-Ayers; Laurence Stensland; W Garrett Nichols; Lawrence Corey
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

6.  Effect of delayed specimen processing on cytomegalovirus antigenemia test results.

Authors:  M L Landry; D Ferguson; S Cohen; K Huber; P Wetherill
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

7.  Rapid cytomegalovirus pp65 antigenemia assay by direct erythrocyte lysis and immunofluorescence staining.

Authors:  S K Ho; C Y Lo; I K Cheng; T M Chan
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948

8.  Evaluation of CMV Brite kit for detection of cytomegalovirus pp65 antigenemia in peripheral blood leukocytes by immunofluorescence.

Authors:  M L Landry; D Ferguson; T Stevens-Ayers; M W de Jonge; M Boeckh
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

9.  Detection of cytomegalovirus in blood donors by PCR using the digene SHARP signal system assay: effects of sample preparation and detection methodology.

Authors:  M Krajden; P Shankaran; C Bourke; W Lau
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

Review 10.  Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantation.

Authors:  Raymund R Razonable; Randall T Hayden
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.